Top compounds associated with response to NECAB2


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel CCLE pan-cancer AAC 0.11 0.02
mRNA Crizotinib gCSI pan-cancer AAC 0.14 0.02
mRNA AEW541 CCLE pan-cancer AAC 0.11 0.02
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.02
mRNA BRD-K52037352 CTRPv2 pan-cancer AAC 0.095 0.02
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.082 0.02
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC 0.17 0.02
mRNA erismodegib CTRPv2 pan-cancer AAC 0.086 0.02
mRNA PD173074 GDSC1000 pan-cancer AAC 0.078 0.02
mRNA SID 26681509 CTRPv2 pan-cancer AAC -0.085 0.02
Download CSV